19 April 2013 | News | By BioSpectrum Bureau
Its a new dawn for Medworxx as EQhealth helps it venture into Kangaroo land
Singapore: Canada-based Medworxx Solutions is expanding into Australia with its partner, EQhealth. Medworxx and EQhealth are performing patient flow diagnostic audits at Eastern Health and Cabrini Health in Australia.
Similar audits in the UK have proven to be effective in identifying hospital patient flow barriers and delays. Two UK patient flow diagnostic audit sites, Royal Liverpool and Broadgreen University Hospitals, and South Tees Hospitals NHS Foundation Trust, became users of the Medworxx Patient Flow solution.
"I am very excited to be working with the Medworxx team and their solution. There is great applicability in the Australian hospital market with access, patient flow, and readmission rates being high areas of focus," said Ms Anita Grindlay, director, EQhealth.
She added, "The provision of real time utilisation data from the Medworxx solution will provide hospitals with the information needed to facilitate improvements in efficiency and effectiveness of care which is of benefit to hospitals, patients, and payers."
"Australia, because of its health system similarities, represents a great opportunity for Medworxx. Early indications show that Medworxx meets a universal need to measure and monitor appropriate lengths of stay," said Mr Dan Matlow, CEO and president, Medworxx. "With 33 percent of the Canadian acute-care beds, and approximately 2,000 UK hospital beds, our technology and methodology is validated and proven to be effective, and we look forward to seeing its adoption in Australia."